INT338934

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.40
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.15
Pain Relevance 0.20

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Slc46a1) plasma membrane (Slc46a1) transmembrane transport (Slc46a1)
cytoplasm (Slc46a1)
Slc46a1 (Mus musculus)
Pain Link Frequency Relevance Heat
methotrexate 70 94.56 High High
Arthritis 27 55.36 Quite High
adenocard 8 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Glutamate 2 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Bioavailability 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Rheumatoid Arthritis 11 94.28 High High
Juvenile Chronic Polyarthritis 23 55.36 Quite High
Toxicity 22 42.16 Quite Low
Targeted Disruption 2 38.40 Quite Low
Disease 11 5.00 Very Low Very Low Very Low
Adverse Drug Reaction 4 5.00 Very Low Very Low Very Low
Arthritis 3 5.00 Very Low Very Low Very Low
INFLAMMATION 2 5.00 Very Low Very Low Very Low
Cancer 2 5.00 Very Low Very Low Very Low
Alopecia 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In addition, proton-pump inhibitors also inhibit PCFT transport function [59, 60], with the potential for clinically important consequences given that they often are coadministered with MTX in RA patients.
Negative_regulation (inhibit) of PCFT associated with rheumatoid arthritis and methotrexate
1) Confidence 0.40 Published 2010 Journal Human Genomics and Proteomics : HGP Section Body Doc Link PMC2958653 Disease Relevance 0.15 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox